TERN
USDTerns Pharmaceuticals Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$15.500
Máximo
$18.740
Mínimo
$15.500
Volumen
4.37M
Fundamentos de la Empresa
Capitalización de Mercado
1.5B
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
1.85M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Truist Securities Reiterates Buy on Terns Pharma, Raises Price Target to $28
Truist Securities analyst Srikripa Devarakonda reiterates Terns Pharma with a Buy and raises the price target from $20 to $28.
BMO Capital Maintains Outperform on Terns Pharma, Raises Price Target to $22
BMO Capital analyst Etzer Darout maintains Terns Pharma with a Outperform and raises the price target from $15 to $22.
Barclays Maintains Overweight on Terns Pharma, Raises Price Target to $27
Barclays analyst Etzer Darout maintains Terns Pharma with a Overweight and raises the price target from $14 to $27.
HC Wainwright & Co. Upgrades Terns Pharma to Buy, Announces $20 Price Target
HC Wainwright & Co. analyst Andres Y. Maldonado upgrades Terns Pharma from Neutral to Buy and announces $20 price target.
William Blair Upgrades Terns Pharma to Outperform
William Blair analyst Andy Hsieh upgrades Terns Pharma from Market Perform to Outperform.
Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades
Terns Pharmaceuticals shares rise after TERN-701 shows a 75% response rate in the CML trial, and William Blair upgrades the stock to Outperform.
Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting
Unprecedented Phase 1 CML efficacy data with 64% MMR achievement by 24 weeks in a refractory patient population Encouraging safety and tolerability profile at all doses evaluated Company to host investor update call on
Acciones Relacionadas
CYCCP
Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock
CTKB
Cytek Biosciences Inc.
DAWN
Day One Biopharmaceuticals Inc.
RGTIW
Rigetti Computing Inc. Warrants
BYFC
Broadway Financial Corporation
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.